Sign in
4

Changes in Ownership

HALOZYME THERAPEUTICS, INC. Filed Acc 0001179110-20-009905

SVP, Chief Technical Officer sold 12,000 shares at $26.91 ($322,884)

From the SEC's structured data for this filing

Trades in this filing

LaBarre Michael J. · SVP, Chief Technical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-09-21 Sale : show line 1 in the form −12,000 $26.91 $322,884 158,800 D
Open-market sales · 12,000 sh · avg $26.91 · $322,884
Loading xslF345X03/edgar.xml…